Does CAPLACIZUMAB Cause Maternal exposure during pregnancy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Maternal exposure during pregnancy have been filed in association with CAPLACIZUMAB (Cablivi). This represents 6.9% of all adverse event reports for CAPLACIZUMAB.
10
Reports of Maternal exposure during pregnancy with CAPLACIZUMAB
6.9%
of all CAPLACIZUMAB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From CAPLACIZUMAB?
Of the 10 reports, 1 (10.0%) resulted in death, and 3 (30.0%) were considered life-threatening.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB Cause?
Off label use (26)
Condition aggravated (13)
Platelet count decreased (12)
Drug ineffective (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Foetal growth restriction (9)
Haemorrhage (9)
Deep vein thrombosis (8)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which CAPLACIZUMAB Alternatives Have Lower Maternal exposure during pregnancy Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL